VRTX

VRTX Net Receivables

$2.13BQuarterly · USD

Period ending:

VRTX FY Net ReceivablesUSD
VRTX FY Net Receivables1990-12-31: $0.001991-12-31: $0.001992-12-31: $0.001993-12-31: $0.001994-12-31: $0.001995-12-31: $0.001996-12-31: $0.001997-12-31: $0.001998-12-31: $0.001999-12-31: $5.96M2000-12-31: $33.91M2001-12-31: $20.27M2002-12-31: $13.20M2003-12-31: $7.32M2004-12-31: $11.89M2005-12-31: $20.60M2006-12-31: $62.92M2007-12-31: $31.32M2008-12-31: $23.49M2009-12-31: $9.60M2010-12-31: $12.53M2011-12-31: $183.14M2012-12-31: $143.25M2013-12-31: $93.48M2014-12-31: $90.06M2015-12-31: $188.52M2016-12-31: $235.48M2017-12-31: $385.99M2018-12-31: $409.69M2019-12-31: $633.52M2020-12-31: $885.40M2021-12-31: $1.14B2022-12-31: $1.44B2023-12-31: $1.56B2024-12-31: $1.61B2025-12-31: $2.05B$2.05B$0.00
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

VRTX net receivables history

Net amount expected from customer receivables. The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.

Vertex Pharmaceuticals Net Receivables — Annual fiscal periods (USD)
Period endingNet Receivables (USD)
2,052,800,000
1,609,400,000
1,563,400,000
1,442,200,000
1,136,800,000
885,400,000
633,518,000
409,688,000
385,992,000
235,483,000
188,520,000
90,057,000
93,476,000
143,250,000
183,135,000
12,529,000
9,601,000
23,489,000
31,320,000
62,923,000
20,595,000
11,891,000
7,324,000
13,200,000
20,265,000
33,906,000
5,956,000
0
0
0
0
0
0
0
0
0

Compare net receivables

All VRTX financial metrics · VRTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.